Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-04-25

Clinical Trial Update: Does Alpha-ketoglutarate Supplementation Lower BiologicaL agE in Middle- Aged Adults? [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update assessing whether alpha-ketoglutarate supplementation lowers biological age in middle-aged adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alpha-ketoglutarate (alpha-ketoglutarate)

Snippet

Sponsor: National University of Singapore | Conditions: Aging | Phase 2 | Status: UNKNOWN